Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $4 | $31 | $12 | $9 |
| - Cash | $10 | $21 | $1 | $4 |
| + Debt | $2 | $1 | $8 | $2 |
| Enterprise Value | -$4 | $11 | $19 | $7 |
| Revenue | $1 | $1 | $1 | $7 |
| % Growth | -42% | 32.4% | -88.1% | – |
| Gross Profit | -$0 | -$1 | -$0 | $4 |
| % Margin | -51.4% | -60.9% | -27% | 49.3% |
| EBITDA | -$15 | -$16 | -$5 | -$2 |
| % Margin | -2,232.9% | -1,368.1% | -583.9% | -30.3% |
| Net Income | -$23 | -$46 | -$9 | -$7 |
| % Margin | -3,406.9% | -4,015.2% | -1,060.7% | -91.8% |
| EPS Diluted | -3.87 | -10.19 | -18.5 | -17.4 |
| % Growth | 62% | 44.9% | -6.3% | – |
| Operating Cash Flow | -$14 | -$17 | -$6 | -$9 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$14 | -$18 | -$6 | -$9 |